---
title: "Mesna"
slug: "MESNA"
date: "2023-06-02"
enableToc: false
tags:
  - building
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[cyclophosphamide]]

# Mesna

## é©æ‡‰ç—‡

å°¿è·¯ä¿è­·åŠ‘ï¼šé˜²æ­¢ OXAZAPHOSPHORINES é¡è—¥ç‰©æ‰€å¼•èµ·å‡ºè¡€æ€§è†€èƒ±ç™¼ç‚ã€‚

## ç”¨æ³•ç”¨é‡

éœè„ˆæ³¨å°„ï¼ŒåŠ‘é‡ç›¸ç•¶æ–¼ Oxazaphosphorine åŠ‘é‡ä¹‹ 20%

- èˆ‡ Oxazphosphorine ä¸€èµ·çµ¦è—¥ï¼Œç„¶å¾Œæ¯ 4 å°æ™‚ä¸€æ¬¡ã€‚

## Absorption

Urinary bioavailability of oral mesna is â†’ 45% to 79%.

## Distribution

Protein binding is â†’ 69% to 75%; Vd is â†’ 0.652 L/kg.

## Metabolism

The major metabolite is â†’ dimesna.

## Elimination

Approximately 32% is â†’ excreted in urine within 24 h. The t Â½ is â†’ 1.2 to 8.3 h (after IV plus oral dose); the plasma Cl is â†’ 1.23 L/kg/h.

The mesna disulfide is â†’ reduced to the free thiol compound that reacts chemically with the urotoxic ifosfamide metabolites, resulting in their detoxification. at â†£ doses of 2 to 4 g, the terminal elimination t Â½ is â†’ approximately 4 to 8 h. It is â†’ rapidly eliminated by the kidneys.
